OBSOLETE: Oculocerebral dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2705
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculocerebral dysplasia, also sometimes called Kaufman oculocerebrofacial syndrome, is an extremely rare condition that affects the development of the eyes and brain. The term 'OBSOLETE' in its classification means that this condition may have been reclassified or merged with another diagnosis in modern medical databases, but historical cases have been described in the medical literature. In the reported cases, affected individuals were born with significant abnormalities of the eyes (such as very small eyes or absent eyes), along with brain malformations that led to severe intellectual disability and developmental delays. Facial features may also be distinctive. Because so few cases have ever been reported in the medical literature, knowledge about this condition is very limited. There is no specific cure or targeted treatment available. Management has been supportive, focusing on addressing individual symptoms such as vision problems, seizures, feeding difficulties, and developmental support. Families affected by this condition benefit from working with a team of specialists to address the wide range of possible symptoms. Given the obsolete classification, patients and families should discuss with their geneticist whether a more current diagnosis or classification applies to their situation.

Also known as:

Key symptoms:

Very small or absent eyes (microphthalmia or anophthalmia)Severe intellectual disabilityBrain malformationsSeizuresDistinctive facial featuresFeeding difficulties in infancyDelayed development of motor skillsShort stature or growth problemsLow muscle toneVision loss or blindness

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Oculocerebral dysplasia.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Oculocerebral dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Oculocerebral dysplasia community →

No specialists are currently listed for OBSOLETE: Oculocerebral dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Oculocerebral dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Oculocerebral dysplasiaForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Oculocerebral dysplasia.

Start the conversation →

Latest news about OBSOLETE: Oculocerebral dysplasia

No recent news articles for OBSOLETE: Oculocerebral dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has modern genetic testing been done to confirm or update this diagnosis?,Could this condition be reclassified under a more current diagnosis?,What brain abnormalities were found on imaging, and what do they mean for my child?,What is the best plan for managing seizures?,What feeding support options are available?,Are there any clinical trials or research studies we could participate in?,What early intervention and therapy services should we start right away?

Common questions about OBSOLETE: Oculocerebral dysplasia

What is OBSOLETE: Oculocerebral dysplasia?

Oculocerebral dysplasia, also sometimes called Kaufman oculocerebrofacial syndrome, is an extremely rare condition that affects the development of the eyes and brain. The term 'OBSOLETE' in its classification means that this condition may have been reclassified or merged with another diagnosis in modern medical databases, but historical cases have been described in the medical literature. In the reported cases, affected individuals were born with significant abnormalities of the eyes (such as very small eyes or absent eyes), along with brain malformations that led to severe intellectual disabi

How is OBSOLETE: Oculocerebral dysplasia inherited?

OBSOLETE: Oculocerebral dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Oculocerebral dysplasia typically begin?

Typical onset of OBSOLETE: Oculocerebral dysplasia is neonatal. Age of onset can vary across affected individuals.